Creoptix
Wadenswil
About Creoptix
Creoptix is a private company headquartered in Wädenswil, near Zurich, Switzerland, with a US office in the Boston area. Creoptix focuses on next-generation bioanalytical instruments for drug discovery and life sciences for both industry and academic research. Based on its proprietary sensor and microfluidics technology, the Creoptix® WAVEsystem provides exceptionally high sensitivity and resolution to study real-time biological interactions involving small molecules, peptides, membrane proteins, biologics, and other molecules even in biofluids like undiluted serum or plasma. Engineered around the proprietary Grating-Coupled Interferometry (GCI) technology, the Creoptix® WAVEsystem delivers high-quality kinetic data across a broader range of samples than traditional SPR equipment.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $11.3M
- Funding stage: M&A
- Last round: Series C (Sep 2019)
- Website: creoptix.com
- Phone: +41 44 533 26 60
Industries & Categories
Biotechnology, Manufacturing
Social Profiles
Canonical: https://fsome.com/organization/creoptix-4596 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.